Source: Medicaldevice-network

Kyruus: Kyruus gets grant for real-time filtering of medical provider referrals during patient interactions

According to GlobalData's company profile on Kyruus , AI for workflow management was a key innovation area identified from patents. Kyruus 's grant share as of July 2024 was 18%. Grant share is based on the ratio of number of grants to total number of patents. Real-time filtering of medical provider referrals during patient interactions The patent US12057226B2 outlines a method for enhancing patient-operator interactions by filtering medical provider search results in real-time. The process begins with an analysis engine receiving an identification of a clinical need for an appointment during the interaction. It analyzes this need alongside patient data to determine specific patient requirements. The engine then identifies potential medical providers whose profiles meet these requirements and generates questions to ascertain whether the patient satisfies any additional medical provider requirements. The user interface is dynamically modified to include these questions, allowing for immediate input from the patient, which further refines the list of potential referrals. Additionally, the method includes features for scheduling appointments and managing provider availability. If a medical provider is found to be unavailable, the system removes them from the list of potential referrals, ensuring that the operator has access to only those providers who can accommodate the patient's needs. The analysis engine is designed to be dynamically updatable, allowing it to adapt in real-time based on the interaction. This innovative approach aims to streamline the referral process, improve patient experience, and enhance the efficiency of healthcare interactions. To know more about GlobalData's detailed insights on Kyruus , buy the report here.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Graham Gardner's photo - Co-Founder & CEO of Kyruus

Co-Founder & CEO

Graham Gardner

CEO Approval Rating

87/100

Read more